Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Pharmaceutical Excipients Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The pharmaceutical excipients market size has demonstrated significant expansion in recent years. It is anticipated to grow from $10822.05 billion in 2025 to $11529.87 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. This growth observed in the past can be attributed to factors such as the escalating demand for oral formulations, the expansion of pharmaceutical manufacturing in APAC, the increasing adoption of synthetic excipients, rigorous regulatory approvals, and heightened research and development efforts in drug formulation.
The pharmaceutical excipients market is anticipated to undergo significant expansion over the next few years. It is projected to achieve a value of $14867 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. This expected growth throughout the forecast period can be attributed to several factors, including the increasing adoption of personalized medicine, a surge in biopharmaceutical production, the rising demand for natural and clean-label excipients, ongoing technological advancements in excipient synthesis, and the growing presence of contract manufacturing organizations (CMOs). Notable trends during this period are expected to include the development of novel excipient formulations, enhanced drug stability solutions, sophisticated targeted drug delivery systems, a greater focus on natural and plant-based excipients, and the emergence of multi-functional excipients.
Get A Free Sample Report With In-Depth Market Insights:
Pharmaceutical Excipients Market Expansion Drivers: What’s Shaping Future Growth?
The growth in biologics sales is anticipated to significantly advance the pharmaceutical sterility testing market in the future. Biologics, or biological products, are medicines derived from living organisms, encompassing various items such as vaccines, blood and blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Pharmaceutical excipients are utilized within biologics to enhance stability, improve formulation, and ensure optimal delivery of active biological agents. For instance, in October 2024, the Generics and Biosimilars Initiative, a Belgium-based organization providing high-quality, scientific information on generic and biosimilar medicines, reported that two complex drugs, in addition to the nine leading biologics, achieved considerable sales in 2023. Specifically, Novo Nordisk’s Ozempic (semaglutide) and Eli Lilly’s Trulicity (dulaglutide), both used to treat type 2 diabetes, recorded sales of US$14 billion and US$7.2 billion, respectively. This rise in biologics sales is thus driving the pharmaceutical excipients market.
Pharmaceutical Excipients Market Segment Analysis Spotlighting Growth Areas
The pharmaceutical excipients market covered in this report is segmented –
1) By Product: Inorganic Chemicals, Organic Chemicals, Other Products
2) By Functionality: Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities
3) By Type Of Formulation: Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations
Subsegments:
1) By Inorganic Chemicals: Salts, Oxides, Silicates
2) By Organic Chemicals: Sugars, Polymers, Oils And Fats
3) By Other Products: Natural Excipients, Coatings, Antioxidants
Pharmaceutical Excipients Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies within the pharmaceutical excipient market are introducing advanced excipients, such as high-purity excipients, to improve drug formulation stability, enhance bioavailability, and support complex drug delivery systems. High-purity excipients are defined as pharmaceutical excipients that have undergone advanced purification processes to eliminate impurities and contaminants. For instance, in October 2023, Clariant, a Switzerland-based specialty chemical company, unveiled three new VitiPure excipients designed to boost the stability and solubility of active pharmaceutical ingredients (APIs). These products include VitiPure O 80 Superior, a high-purity polysorbate 80; VitiPure CO 35 Superior, a polyoxyl 35 castor oil; and VitiPure Meglumine LEX, a solubilizer featuring low bioburden. These excipients, targeting diverse drug delivery applications, particularly sensitive formulations like mRNA vaccines and biologics, address the increasing requirement for high-purity ingredients while complying with stringent regulatory standards.
Pharmaceutical Excipients Market Leading Companies: Who Holds The Strongest Market Presence?
Major companies operating in the pharmaceutical excipients market are BASF SE, Ashland Global Holdings, Evonik Industries AG, International Flavors & Fragrances Inc, Roquette Frères, Archer Daniels Midland Company, Lubrizol Corporation, Croda International Plc, Kerry Group, DuPont de Nemours Inc., Amster Microcell Private Limited, Finar Limited, P. D. Polychem Private Limited, CAD Pharma Inc, Maas Pharma Chemicals, Aeon Procare Private Limited, CSPC Pharmaceutical Group Ltd, Allen & Hanburys Ltd, Colorcon, MEGGLE GmbH & Co. KG, DMV-Fonterra Excipients GmbH & Co. KG, Alpen Pharma AG, Avantor Inc, JRS PHARMA GmbH & Co. KG, The Dow Chemical Co, EMS Pharma, Biolab Farmaceutica, Medist FZE, W.R. Grace, Univar Solutions, Nitika Pharma, DFE Pharma, Cargill, Sensient Pharma
View The Full Pharmaceutical Excipients Market Report:
Pharmaceutical Excipients Market Geographic Spread And Regional Opportunities
North America is the largest region in the pharmaceutical excipients market in 2025. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in the pharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
